Ligands for flt3 receptors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7041282
APP PUB NO 20020107365A1
SERIAL NO

09983806

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to flt3-L as an isolated protein, the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, compositions comprising flt3-L, methods of improving gene transfer to a mammal using flt3-L, and methods of improving transplantations using fit3-L. Flt3-L finds use in treating patients with anemia, AIDS and various cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELLDEX THERAPEUTICS INC53 FRONTAGE ROAD SUITE 200 HAMPTON NJ 08827

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beckmann, M Patricia Poulsbo, WA 44 1086
Lyman, Stewart D Seattle, WA 38 273

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation